Guggenheim Downgrades Benitec BioPharma (BNTC) to Neutral

June 10, 2026 6:47 AM

Guggenheim analyst Debjit Chattopadhyay downgraded Benitec BioPharma (NASDAQ: BNTC) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found